EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates

Agustiningsih Agustiningsih iD, Muhammad Rezki Rasyak iD, Turyadi iD, Sri Jayanti iD, Caecilia Sukowati iD

Exploration of Targeted Anti-tumor Therapy · 20.02.2024 · 5 (1) · 120-134

DOI: 10.37349/etat.2024.00209 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Exploration of Targeted Anti-tumor Therapy, online erschienen am 20.02.2024. Verfasst von Agustiningsih Agustiningsih und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eijkman Research Center for Molecular Biology, National Research and Innovation Agency of Indonesia (BRIN), Jakarta Pusat 10340, Indonesia. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers with high mortality rate. Among its various etiological factors, one of the major risk factors for HCC is a chronic infection of hepatitis B virus (HBV). HBV X protein (HBx) has been identified to play an important role in the HBV-induced HCC pathogenesis since it may interfere with several key regulators of many cellular processes. HBx localization within the cells may be beneficial to HBx multiple functions at different phases of HBV infection and associated hepatocarcinogenesis. HBx as a regulatory protein modulates cellular transcription, molecular signal transduction, cell cycle, apoptosis, autophagy, protein degradation pathways, and host genetic stability via interaction with various factors, including its association with various non-coding RNAs. A better understanding on the regulatory mechanism of HBx on various characteristics of HCC would provide an overall picture of HBV-associated HCC. This article addresses recent data on HBx role in the HBV-associated hepatocarcinogenesis.

Schlagwörter

Stichwörter der Autor:innen

Hepatitis B virushepatitis B virus X proteinhepatocellular carcinomasignalling pathways

Autor:innen und Institutionen

  • Eijkman Research Center for Molecular Biology, National Research and Innovation Agency of Indonesia (BRIN), Jakarta Pusat 10340, Indonesia.
  • Post Graduate School, Faculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia.
  • Liver Cancer Unit, Fondazione Italiana Fegato ONLUS, AREA Science Park, Basovizza, 34149 Trieste, Italy.

ORCID-Profile: Agustiningsih Agustiningsih, Muhammad Rezki Rasyak, Turyadi, Sri Jayanti, Caecilia Sukowati

Zitieren

APA

Agustiningsih, A., Rasyak, M. R., Turyadi, Jayanti, S., & Sukowati, C. (2024). The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates. Exploration of Targeted Anti-tumor Therapy, 5(1), 120-134. https://doi.org/10.37349/etat.2024.00209

Vancouver

Agustiningsih A, Rasyak MR, Turyadi, Jayanti S, Sukowati C. The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates. Exploration of Targeted Anti-tumor Therapy. 2024;5(1):120-134. doi:10.37349/etat.2024.00209

BibTeX
@article{Agustiningsih2024,
  author = {Agustiningsih, Agustiningsih and Rasyak, Muhammad Rezki and Turyadi and Jayanti, Sri and Sukowati, Caecilia},
  title = {The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates},
  journal = {Exploration of Targeted Anti-tumor Therapy},
  year = {2024},
  volume = {5},
  number = {1},
  pages = {120--134},
  doi = {10.37349/etat.2024.00209}
}
Kostenlos starten →